Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03721653 |
|---|---|
| Brief Title: | FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients (AtezoTRIBE) |
| First Submitted : | October 25, 2018 |
| First Submitted that Met QC Criteria : | October 25, 2018 |
| First Posted : | October 26, 2018 |
| Last Update Submitted that Met QC Criteria : | October 11, 2023 |
| Last Update Posted : | October 12, 2023 |